These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19944774)

  • 1. Going green in Cryptococcus neoformans: the recycling of a selectable drug marker.
    Patel RD; Lodge JK; Baker LG
    Fungal Genet Biol; 2010 Mar; 47(3):191-8. PubMed ID: 19944774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple gene deletion in Cryptococcus neoformans using the Cre-lox system.
    Baker LG; Lodge JK
    Methods Mol Biol; 2012; 845():85-98. PubMed ID: 22328369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biolistic Transformation of Cryptococcus neoformans.
    Toffaletti DL; Tenor JL; Perfect JR
    Methods Mol Biol; 2024; 2775():59-79. PubMed ID: 38758311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unintended Side Effects of Transformation Are Very Rare in
    Friedman RZ; Gish SR; Brown H; Brier L; Howard N; Doering TL; Brent MR
    G3 (Bethesda); 2018 Mar; 8(3):815-822. PubMed ID: 29305388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid mapping of insertional mutations to probe cell wall regulation in Cryptococcus neoformans.
    Esher SK; Granek JA; Alspaugh JA
    Fungal Genet Biol; 2015 Sep; 82():9-21. PubMed ID: 26112692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of positive selectable markers for the fungal pathogen Cryptococcus neoformans.
    Hua J; Meyer JD; Lodge JK
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):125-8. PubMed ID: 10618292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption.
    Sudarshan S; Davidson RC; Heitman J; Alspaugh JA
    Fungal Genet Biol; 1999 Jun; 27(1):36-48. PubMed ID: 10413613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dominant selectable marker for use in Cryptococcus neoformans.
    McDade HC; Cox GM
    Med Mycol; 2001 Feb; 39(1):151-4. PubMed ID: 11270405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring redundancy in the yeast genome: an improved strategy for use of the cre-loxP system.
    Delneri D; Tomlin GC; Wixon JL; Hutter A; Sefton M; Louis EJ; Oliver SG
    Gene; 2000 Jul; 252(1-2):127-35. PubMed ID: 10903444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorogenic C. neoformans reporter strain with a robust expression of m-cherry expressed from a safe haven site in the genome.
    Upadhya R; Lam WC; Maybruck BT; Donlin MJ; Chang AL; Kayode S; Ormerod KL; Fraser JA; Doering TL; Lodge JK
    Fungal Genet Biol; 2017 Nov; 108():13-25. PubMed ID: 28870457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene disruption in Cryptococcus neoformans using double-joint PCR with split dominant selectable markers.
    Kim MS; Kim SY; Jung KW; Bahn YS
    Methods Mol Biol; 2012; 845():67-84. PubMed ID: 22328368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diversity of retrotransposons in the yeast Cryptococcus neoformans.
    Goodwin TJ; Poulter RT
    Yeast; 2001 Jun; 18(9):865-80. PubMed ID: 11427969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements to gene deletion in the fungal pathogen Cryptococcus neoformans: absence of Ku proteins increases homologous recombination, and co-transformation of independent DNA molecules allows rapid complementation of deletion phenotypes.
    Goins CL; Gerik KJ; Lodge JK
    Fungal Genet Biol; 2006 Aug; 43(8):531-44. PubMed ID: 16714127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a complete URA5 deletion strain of a human pathogenic yeast Cryptococcus neoformans.
    Drivinya A; Shimizu K; Takeo K
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(1):1-6. PubMed ID: 14765094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A family of removable cassettes designed to obtain antibiotic-resistance-free genomic modifications of Escherichia coli and other bacteria.
    Palmeros B; Wild J; Szybalski W; Le Borgne S; Hernández-Chávez G; Gosset G; Valle F; Bolivar F
    Gene; 2000 Apr; 247(1-2):255-64. PubMed ID: 10773465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-assisted genetic dissection of pathogenicity and drug resistance in the opportunistic human pathogenic fungus Cryptococcus neoformans.
    Kim H; Jung KW; Maeng S; Chen YL; Shin J; Shim JE; Hwang S; Janbon G; Kim T; Heitman J; Bahn YS; Lee I
    Sci Rep; 2015 Mar; 5():8767. PubMed ID: 25739925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Transcription Factor Pdr802 Regulates Titan Cell Formation and Pathogenicity of Cryptococcus neoformans.
    Reuwsaat JCV; Agustinho DP; Motta H; Chang AL; Brown H; Brent MR; Kmetzsch L; Doering TL
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688010
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequence length required for homologous recombination in Cryptococcus neoformans.
    Nelson RT; Pryor BA; Lodge JK
    Fungal Genet Biol; 2003 Feb; 38(1):1-9. PubMed ID: 12553931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans.
    Chang YC; Kwon-Chung KJ
    J Bacteriol; 1999 Sep; 181(18):5636-43. PubMed ID: 10482503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Amino Acid Permeases and Tryptophan Biosynthesis in Cryptococcus neoformans Survival.
    Fernandes JD; Martho K; Tofik V; Vallim MA; Pascon RC
    PLoS One; 2015; 10(7):e0132369. PubMed ID: 26162077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.